Alcohol
Volume 43, Issue 7 , Pages 555-558 , November 2009

Role of the GABAB receptor in alcohol-seeking and drinking behavior

Received 16 December 2008 ,Revised 6 May 2009 ,Accepted 11 August 2009.

References 

  1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II—preliminary clinical evidence. Alcohol. Clin. Exp. Res. 2000;24:67–71
  2. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, et al. Baclofen efficacy in reducing alcohol craving and intake—a preliminary double-blind randomised controlled study. Alcohol Alcohol. 2002;37:504–508
  3. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am. J. Med. 2002;112:226–229
  4. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, et al. Baclofen in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus diazepam. Am. J. Med. 2006;119:276.e13–276.e18
  5. Addolorato G, Leggio L, Abenavoli L, DeLorenzi G, Parente A, Caputo F, et al. Suppression of alcohol delirium tremens by baclofen administration: a case report. Clin. Neuropharmacol. 2003;26:258–262
  6. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370:1915–1922
  7. Agabio R, Marras P, Addolorato G, Carpiniello B, Gessa GL. Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report. J. Clin. Psychopharmacol. 2007;27:319–320
  8. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 2005;40:147–150
  9. Anstrom KK, Cromwell HC, Markowski T, Woodward DJ. Effect of baclofen on alcohol and sucrose self-administration in rats. Alcohol. Clin. Exp. Res. 2003;27:900–908
  10. Bechtholt AJ, Cunningham CL. Ethanol-induced conditioned place preference is expressed through a ventral tegmental area dependent mechanism. Behav. Neurosci. 2005;119:213–223
  11. Besheer J, Lepoutre V, Hodge CW. GABAB receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology. 2004;174:358–366
  12. Boehm SL, Piercy MM, Bergstrom HC, Phillips TJ. Ventral tegmental area region governs GABAB receptor modulation of ethanol-stimulated activity in mice. Neuroscience. 2002;115:185–200
  13. Broadbent J, Harless WE. Differential effects of GABAA and GABAB agonists on sensitization to the locomotor stimulant effects of ethanol in DBA/2J mice. Psychopharmacology. 1999;141:197–205
  14. Bucknam W. Suppression of symptoms of alcohol dependence and craving using high dose baclofen. Alcohol Alcohol. 2007;42:158–160
  15. Chester JA, Cunningham CL. Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol. Biochem. Behav. 1999;63:325–331
  16. Colombo G, Agabio R, Carai MAM, Lobina C, Pani M, Reali R, et al. Ability of baclofen in reducing alcohol intake and withdrawal severity: I—preclinical evidence. Alcohol. Clin. Exp. Res. 2000;24:58–66
  17. Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G, et al. The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol. 2002;37:499–503
  18. Colombo G, Serra S, Brunetti G, Vacca G, Carai MAM, Gessa GL. Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 2003;70:105–108
  19. Colombo G, Serra S, Vacca G, Carai MAM, Gessa GL. Baclofen-induced suppression of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats exposed to different alcohol concentrations. Eur. J. Pharmacol. 2006;550:123–126
  20. Colombo G, Serra S, Vacca G, Gessa GL, Carai MAM. Suppression by baclofen of the stimulation of alcohol intake induced by morphine and WIN 55,212-2 in alcohol-preferring rats. Eur. J. Pharmacol. 2004;492:189–193
  21. Colombo G, Vacca G, Serra S, Brunetti G, Carai MAM, Gessa GL. Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology. 2003;167:221–224
  22. Cott J, Carlsson A, Engel J, Lindqvist M. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn Schmiedebergs Arch. Pharmacol. 1976;295:203–209
  23. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N, N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J. Pharmacol. Exp. Ther. 2004;310:952–963
  24. Daoust M, Saligaut C, Lhuintre JP, Moore N, Flipo JL, Boismare F. GABA transmission, but not benzodiazepine receptor stimulation, modulates ethanol intake by rats. Alcohol. 1987;4:469–472
  25. Filip M, Frankowska M. Effects of GABAB receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur. J. Pharmacol. 2007;571:166–173
  26. Filip M, Frankowska M, Przegaliński E. Effects of GABAB receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur. J. Pharmacol. 2007;574:148–157
  27. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol. Clin. Exp. Res. 2004;28:1517–1523
  28. Guery S, Floersheim P, Kaupmann K, Froestl W. Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABAB receptors. Bioorg. Med. Chem. Lett. 2007;17:6206–6211
  29. Jacobson LH, Cryan JF. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Neuropharmacology. 2008;54:854–862
  30. Janak PH, Gill TM. Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol. 2003;30:1–7
  31. Knapp DJ, Overstreet DH, Breese GR. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol. Clin. Exp. Res. 2007;31:582–595
  32. Leite-Morris KA, Czachowski CL. Intra-ventral tegmental area microinjections of a GABA receptor agonist dose-dependently attenuate ethanol seeking in rats. Alcohol. Clin. Exp. Res. 2006;30:182A
  33. Leite-Morris KA, Misch ES, Czachowski CL. Intra-VTA activation of GABA(B) receptors modulates accumbal dopamine during ethanol seeking behavior. Alcohol. Clin. Exp. Res. 2008;32:276A
  34. Lhuillier L, Mombereau C, Cryan JF, Kaupmann K. GABAB receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology. 2007;32:388–398
  35. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, et al. The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology. 2006;50:632–639
  36. Maccioni P, Bienkowski P, Carai MAM, Gessa GL, Colombo G. Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 2008;95:284–287
  37. Maccioni P, Fantini N, Froestl W, Carai MAM, Gessa GL, Colombo G. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783—comparison with the effect of the GABAB receptor direct agonist, baclofen. Alcohol. Clin. Exp. Res. 2008;32:1558–1564
  38. Maccioni P, Pes D, Orrù A, Froestl W, Gessa GL, Carai MAM, et al. Reducing effect of the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in alcohol-preferring rats. Psychopharmacology. 2007;193:171–178
  39. Maccioni P, Serra S, Vacca G, Orrù A, Pes D, Agabio R, et al. Baclofen-induced reduction of alcohol reinforcement in alcohol-preferring rats. Alcohol. 2005;36:161–168
  40. Malherbe P, Masciadri R, Norcross RD, Knoflach F, Kratzeisen C, Zenner MT, et al. Characterization of (R, S)-5,7-di- tert-butyl-3-hydroxy-3-trifluoromethyl-3 H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors. Br. J. Pharmacol. 2008;154:797–811
  41. Mombereau C, Lhuillier L, Kaupmann K, Cryan J. GABAB receptor positive modulation-induced blockade of the rewarding properties of nicotine is associated with a reduction in nucleus accumbens δFosB accumulation. J. Pharmacol. Exp. Ther. 2007;321:172–177
  42. Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, et al. Reducing effect of the positive allosteric modulators of the GABAB receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur. J. Pharmacol. 2005;525:105–111
  43. Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A. Positive modulation of GABAB receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J. Pharmacol. Exp. Ther. 2008;326:306–314
  44. Perfumi M, Santoni M, Ciccocioppo R, Massi M. Blockade of γ-aminobutyric acid receptors does not modify the inhibition of ethanol intake induced by Hypericum perforatum in rats. Alcohol Alcohol. 2002;37:540–546
  45. Petry NM. Benzodiazepine-GABA modulation of concurrent ethanol and sucrose reinforcement in the rat. Exp. Clin. Psychopharmacol. 1997;5:183–194
  46. Quintanilla ME, Perez E, Tampier L. Baclofen reduces ethanol intake in high-alcohol-drinking University of Chile bibulous rats. Addict. Biol. 2008;13:326–336
  47. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 1993;18:247–291
  48. Shen EH, Dorow J, Harland R, Burkhart-Kasch S, Phillips TJ. Seizure sensitivity and GABAergic modulation of ethanol sensitivity in selectively bred FAST and SLOW mouse lines. J. Pharmacol. Exp. Ther. 1998;287:606–615
  49. Slattery DA, Markou A, Froestl W, Cryan JF. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology. 2005;30:2065–2072
  50. Smith MA, Yancey DL, Morgan D, Froestl W, Roberts DCS. Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology. 2004;173:105–111
  51. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, et al. Positive allosteric modulation of native and recombinant γ-aminobutyric acidB receptors by 2,6-di- tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol. 2001;60:963–971
  52. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, et al. N, N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J. Pharmacol. Exp. Ther. 2003;307:322–330
  53. Walker BM, Koob GF. The γ-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 2007;31:11–18
  54. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol. Rev. 1987;94:469–492

PII: S0741-8329(09)00162-1

doi: 10.1016/j.alcohol.2009.09.030

Alcohol
Volume 43, Issue 7 , Pages 555-558 , November 2009

Article Tools